Shigeru Sumitomo

DBJ Capital Co. Ltd. (DBJ Capital) is a private equity and venture capital subsidiary of the Development Bank of Japan, Inc., which is ultimately owned by the Government of Japan. The firm was founded in 2005, and is headquartered in Tokyo, Japan.

PRISM Pharma Co., Ltd. operates as a pharmaceutical company that focuses on discovery and development of small molecules to modulate protein-protein interactions. It utilizes protein secondary structure mimetic library, which modulates intracellular protein and protein interactions. The firm develops an anti-cancer drug CP/Catenin inhibitor PRI-724 that acts on both cancer cells and cancer stem cells that can switch from proliferation to differentiation. The company was founded by Hiroyuki Kouji on November 2, 2006 and is headquartered in Fujisawa, Japan.

FFG Venture Business Partners KK (FFG Venture) is a venture capital firm which was established in 2016. The firm is a subsidiary of Fukuoka Financial Group, Inc. FFG Venture is headquartered in Fukuoka.